Cellular and humoral immunity elicited by an Influenza A polyvalent virosomal vaccine in pigs. In: INTERNATIONAL PIG VETERINARY SOCIETY CONGRESS, 26., 2022, Rio de Janeiro. Proceedings... Rio de Janeiro, RJ: IPVS: Abraves, 2022. p. 421.

Influenza A virus (IAV) causes economic losses to the swine industry and public health concerns. The IAV is endemic in pigs and genetically and antigenically distinct virus lineages of subtypes H1N1, H1N2 and H3N2 circulate in different geographic regions with limited cross-protection (1, 2). The co-circulation of distinct IAV lineages associated with rapid viral evolution challenges the development of effective vaccines. The aim of this study was to evaluate the immunogenicity of an adjuvanted virosome-based influenza vaccine containing the hemagglutinin (HA) of H1N1pdm, H1N2 and H3N2.

Bibliographic Details

Main Authors:	HAACH, V., BASTOS, A. P. A., GAVA, D., FONSECA, F. M. da, MORES, M. A. Z., COLDEBELLA, A., FRANCO, A. C., SCHAEFER, R.
Other Authors:	VANESSA HAACH, Universidade Federal do Rio Grande do Sul; ANA PAULA ALMEIDA BASTOS, CNPSA; DANIELLE GAVA, CNPSA; FRANCISCO NOE DA FONSECA, GPAR; MARCOS ANTONIO ZANELLA MORES, CNPSA; ARLEI COLDEBELLA, CNPSA; ANA CLAUDIA FRANCO, Universidade Federal do Rio Grande do Sul; REJANE SCHAEFER, CNPSA.
Format:	Parte de livro biblioteca
Language:	Ingles English
Published:	2022-09-20
Subjects:	Imunidade celular, Suinocultura, Vacinação, Vacina Polivalente, Influenza A virus,
Online Access:	http://www.alice.cnptia.embrapa.br/alice/handle/doc/1146658
Tags:	Add Tag No Tags, Be the first to tag this record!